Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels.
Chakfe Y
,
Seguin R
,
Antel JP
,
Morissette C
,
Malo D
,
Henderson D
,
Séguéla P
.
???displayArticle.abstract???
P2X(7) is a subtype of ATP-gated channels that is highly expressed in astrocytes, microglia, and other immune cells. Activation of P2X(7) purinoceptors by ATP or 3'-O-(4-benzoyl)-benzoyl ATP (BzATP) induces the formation of cytolytic pores and provokes release of interleukin-1beta from immune cells. We investigated the actions of other endogenous nucleotides on recombinant and microglial P2X(7) receptors using electrophysiology, fluorescence imaging, and interleukin-1beta release measurement. We found that initial application of ADP or AMP to Xenopus oocytes expressing P2X(7) receptors was ineffective. However, when ADP and AMP, but not UTP or adenosine, were applied after a brief exposure to ATP or BzATP, they activated P2X(7) receptors in a dose-dependent manner. Moreover, responses to ADP and AMP were also elicited after exposure to low concentrations of ATP and were recorded several minutes after removal of ATP from the extracellular medium. Whole-cell recordings from mouse microglial cells showed that significant responses to ADP and AMP were elicited only after ATP application. YO-PRO-1 dye uptake imaging revealed that, unlike ATP, prolonged application of ADP or AMP did not cause an opening of large cytolytic pores in mouse microglial cells. Finally, ADP and AMP stimulated the release of interleukin-1beta from ATP-primed mouse and human microglial cells. We conclude that selective sensitization of P2X(7) receptors to ADP and AMP requires priming with ATP. This novel property of P2X(7) leads to activation by ATP metabolites and proinflammatory cytokine release from microglia without cytotoxicity.
Aloisi,
Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities.
1999, Pubmed
Aloisi,
Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities.
1999,
Pubmed
Baricordi,
Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor.
1999,
Pubmed
Boué-Grabot,
A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X(2) ATP-gated channels.
2000,
Pubmed
,
Xenbase
Buell,
Blockade of human P2X7 receptor function with a monoclonal antibody.
1998,
Pubmed
Buttini,
Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat.
1994,
Pubmed
Chessell,
Cloning and functional characterisation of the mouse P2X7 receptor.
1998,
Pubmed
Collo,
Tissue distribution of the P2X7 receptor.
1997,
Pubmed
Di Virgilio,
ATP receptors and giant cell formation.
1999,
Pubmed
Di Virgilio,
The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death.
1995,
Pubmed
Ferrari,
P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells.
1999,
Pubmed
Ferrari,
ATP-mediated cytotoxicity in microglial cells.
1997,
Pubmed
Ferrari,
Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65.
1997,
Pubmed
Ferrari,
Mouse microglial cells express a plasma membrane pore gated by extracellular ATP.
1996,
Pubmed
Ferrari,
Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin.
1997,
Pubmed
Ferrari,
Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages.
1997,
Pubmed
Garcia,
Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion.
1995,
Pubmed
Giulian,
Interleukin 1 of the central nervous system is produced by ameboid microglia.
1986,
Pubmed
Hibell,
Apparent species differences in the kinetic properties of P2X(7) receptors.
2000,
Pubmed
Hide,
Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia.
2000,
Pubmed
Ho,
Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice.
1997,
Pubmed
Hopkins,
Cytokines and the nervous system. I: Expression and recognition.
1995,
Pubmed
Humphreys,
Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor.
2000,
Pubmed
Kim,
Proteomic and functional evidence for a P2X7 receptor signalling complex.
2001,
Pubmed
Koshimizu,
Contributions of the C-terminal domain to the control of P2X receptor desensitization.
1999,
Pubmed
Kusner,
ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D.
2000,
Pubmed
Li,
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.
2000,
Pubmed
Liu,
Interleukin-1 beta mRNA expression in ischemic rat cortex.
1993,
Pubmed
Mahaut-Smith,
ADP is not an agonist at P2X(1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets.
2000,
Pubmed
,
Xenbase
Martin,
Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats.
1995,
Pubmed
Minami,
Induction of interleukin-1 beta mRNA in rat brain after transient forebrain ischemia.
1992,
Pubmed
Nishimura,
Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's disease.
2000,
Pubmed
Nuttle,
Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes.
1994,
Pubmed
,
Xenbase
Pasinelli,
Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase.
1998,
Pubmed
Perregaux,
Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity.
1994,
Pubmed
Rassendren,
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA.
1997,
Pubmed
Relton,
Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat.
1992,
Pubmed
Righi,
Monokine production by microglial cell clones.
1989,
Pubmed
Rothwell,
The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications.
1997,
Pubmed
Rothwell,
Interleukin 1 in the brain: biology, pathology and therapeutic target.
2000,
Pubmed
Rothwell,
Annual review prize lecture cytokines - killers in the brain?
1999,
Pubmed
Sanz,
Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells.
2000,
Pubmed
Schrijver,
Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS.
1999,
Pubmed
Solle,
Altered cytokine production in mice lacking P2X(7) receptors.
2001,
Pubmed
Surprenant,
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7).
1996,
Pubmed
Traverso-Cori,
Different molecular forms of potato apyrase.
1970,
Pubmed
Vezzani,
Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice.
2000,
Pubmed
Vezzani,
Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures.
1999,
Pubmed
Wang,
Expression of P2y and P2x receptors in cultured human microglia.
1999,
Pubmed
Yamasaki,
Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats.
1995,
Pubmed
Yamasaki,
Possible involvement of interleukin-1 in ischemic brain edema formation.
1992,
Pubmed
Zimmermann,
Extracellular metabolism of ATP and other nucleotides.
2000,
Pubmed
